SAFETY OF BIOLOGICAL PREPARATIONS AND SMALL MOLECULES. ARE THERE ANY DIFFERENCES?
A considerable number of biopharmaceuticals have recently been introduced into clinical practice. Their role is becoming more and more important in managing various diseases, including incapacitating and life-threatening diseases. The authors systematically reviewed literary data from 1990 to 2013 d...
Main Authors: | A. S. Kolbin, A. V. Kharchev |
---|---|
Format: | Article |
Language: | English |
Published: |
Paediatrician Publishers, LLC
2013-05-01
|
Series: | Pediatričeskaâ Farmakologiâ |
Subjects: | |
Online Access: | https://www.pedpharma.ru/jour/article/view/215 |
Similar Items
-
Improved drug safety through intensive pharmacovigilance in hospitalized pediatric patients
by: Alan O. Vázquez-Alvarez, et al.
Published: (2017-12-01) -
DRUG SAFETY MONITORING SERVICE IN DEVELOPING ORGANIZATIONS / MANUFACTURERS OF DRUGS FOR VETERINARY USE
by: N. P. Biryukova, et al.
Published: (2019-09-01) -
Comparing epidemiological methods in detecting drug safety signal in IRAN
by: G Shalviri, et al.
Published: (2005-12-01) -
Fluoroquinolone antibiotics: safety of use by the example of ciprofloxacin
by: N. V. Molchan, et al.
Published: (2019-06-01) -
Topical Issues of Drug Safety, Possibilities of Improving of Pharmacovigilance
by: M. V. Zhuravleva, et al.
Published: (2019-09-01)